Health Care

Commentary

A lawsuit that may kill tomorrow’s cures

On Wednesday, May 6, the California Supreme Court will hear a case that could upend the economics of medical innovation. Roughly 24,000 plaintiffs are suing pharmaceutical company Gilead over one of its HIV drugs. They do not claim that the drug failed to work, nor that it was defectively manufactured, ...
Commentary

Can You Sue A Drug Company For Not Inventing Faster?

This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science. At issue is Gilead Sciences’ HIV treatment tenofovir disoproxil fumarate, or TDF. Tens of thousands of plaintiffs allege they suffered side effects while taking the drug. They are not arguing ...
Commentary

Price Controls Could Prevent the Next ‘Miracle Drug’

The death rate from cancer in the United States has fallen by more than one-third since 1991. HIV-related mortality has dropped ninefold since 1995. Death rates for Alzheimer’s, chronic respiratory diseases, and stroke have all declined in recent years, too. These gains didn’t happen by accident. They’re the result of ...
Commentary

Breaking Up ‘Big Medicine’ Won’t Fix What Washington Broke

Washington is gearing up to crack down on “Big Medicine,” with populist Sens. Elizabeth Warren, D-Mass., and Josh Hawley, R-Mo., leading the charge. Over the past decade, America’s healthcare system has become increasingly consolidated, leaving patients with higher prices, fewer choices, and more bureaucratic frustration. But before lawmakers swing a ...
Commentary

Don’t penalize patients for shopping smart on drugs — reward them

Patients shouldn’t be penalized for finding a better deal on their prescriptions. Too often, they are. Those who pay out of pocket for medications — often at lower prices through direct-to-consumer platforms — typically receive no credit toward their health plan’s annual deductible. Higher-priced drugs purchased through an insurer’s preferred ...
Commentary

Some Never Learn: Dems’ Healthcare Repeats Same Mistakes

Democrats are laying the groundwork for their next healthcare overhaul if they take control of Congress in this fall’s elections. A new report from the Center for American Progress shows exactly what they have in mind, and patients won’t like it. The group has long served as a policy incubator ...
Commentary

Democrats Didn’t Discover The Insurance Crisis. They Created It

Sen. Ron Wyden, D-Ore., recently invited his colleagues to begin a new conversation about reforming the health insurance industry. It’s a conversation worth having. Health insurers have grown bigger, more powerful and more deeply embedded in our healthcare system than ever before—to the detriment of patients and taxpayers alike. But ...
Commentary

Obamacare Crushed Choice. This Reform Helps Restore It

Every fall, millions of Americans log onto the Affordable Care Act’s exchanges hoping to find a health plan that fits their needs. This year, roughly 23 million people have signed up through the marketplaces. Many are discovering that their options all look more or less the same—expensive and ill-suited to ...
commentar

Uninsured Americans Want Coverage Worth Buying

More than 20 million Americans lack health insurance. Democrats are betting that public concern over that number will propel them back into power this fall. But the headline figure obscures a more important question. Why do so many Americans go without coverage? A new report from the Centers for Disease ...
Commentary

Trump’s War on Medicaid Fraud Finally Gains Steam

Vice President J.D. Vance’s effort to clean up waste in Medicaid began in earnest last month, with the first meeting of the administration’s Task Force to Eliminate Fraud. Judging from a new federal report, he’s got his work cut out for him. The study, issued last month by the Office ...
Commentary

A lawsuit that may kill tomorrow’s cures

On Wednesday, May 6, the California Supreme Court will hear a case that could upend the economics of medical innovation. Roughly 24,000 plaintiffs are suing pharmaceutical company Gilead over one of its HIV drugs. They do not claim that the drug failed to work, nor that it was defectively manufactured, ...
Commentary

Can You Sue A Drug Company For Not Inventing Faster?

This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science. At issue is Gilead Sciences’ HIV treatment tenofovir disoproxil fumarate, or TDF. Tens of thousands of plaintiffs allege they suffered side effects while taking the drug. They are not arguing ...
Commentary

Price Controls Could Prevent the Next ‘Miracle Drug’

The death rate from cancer in the United States has fallen by more than one-third since 1991. HIV-related mortality has dropped ninefold since 1995. Death rates for Alzheimer’s, chronic respiratory diseases, and stroke have all declined in recent years, too. These gains didn’t happen by accident. They’re the result of ...
Commentary

Breaking Up ‘Big Medicine’ Won’t Fix What Washington Broke

Washington is gearing up to crack down on “Big Medicine,” with populist Sens. Elizabeth Warren, D-Mass., and Josh Hawley, R-Mo., leading the charge. Over the past decade, America’s healthcare system has become increasingly consolidated, leaving patients with higher prices, fewer choices, and more bureaucratic frustration. But before lawmakers swing a ...
Commentary

Don’t penalize patients for shopping smart on drugs — reward them

Patients shouldn’t be penalized for finding a better deal on their prescriptions. Too often, they are. Those who pay out of pocket for medications — often at lower prices through direct-to-consumer platforms — typically receive no credit toward their health plan’s annual deductible. Higher-priced drugs purchased through an insurer’s preferred ...
Commentary

Some Never Learn: Dems’ Healthcare Repeats Same Mistakes

Democrats are laying the groundwork for their next healthcare overhaul if they take control of Congress in this fall’s elections. A new report from the Center for American Progress shows exactly what they have in mind, and patients won’t like it. The group has long served as a policy incubator ...
Commentary

Democrats Didn’t Discover The Insurance Crisis. They Created It

Sen. Ron Wyden, D-Ore., recently invited his colleagues to begin a new conversation about reforming the health insurance industry. It’s a conversation worth having. Health insurers have grown bigger, more powerful and more deeply embedded in our healthcare system than ever before—to the detriment of patients and taxpayers alike. But ...
Commentary

Obamacare Crushed Choice. This Reform Helps Restore It

Every fall, millions of Americans log onto the Affordable Care Act’s exchanges hoping to find a health plan that fits their needs. This year, roughly 23 million people have signed up through the marketplaces. Many are discovering that their options all look more or less the same—expensive and ill-suited to ...
commentar

Uninsured Americans Want Coverage Worth Buying

More than 20 million Americans lack health insurance. Democrats are betting that public concern over that number will propel them back into power this fall. But the headline figure obscures a more important question. Why do so many Americans go without coverage? A new report from the Centers for Disease ...
Commentary

Trump’s War on Medicaid Fraud Finally Gains Steam

Vice President J.D. Vance’s effort to clean up waste in Medicaid began in earnest last month, with the first meeting of the administration’s Task Force to Eliminate Fraud. Judging from a new federal report, he’s got his work cut out for him. The study, issued last month by the Office ...
Scroll to Top